Instalab
logoInstalab

Factor X Activity

Blood Test
Check the shared clotting protein that can explain bruising or bleeding when broad clotting screens don't name the cause.
4.9 (3,863 reviews)
Tested by Quest Diagnostics
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home or at 2,000+ patient service centers
Get results
Explained with clear next steps, no medical jargon

Should you take a Factor X Activity test?

This test is most useful if any of these apply to you.

Bleeding or Bruising More Than Seems Normal
Frequent nosebleeds, heavy periods, or easy bruising can justify a specific factor X check after broad screens.
A Bleeding Disorder Runs in Your Family
If factor X deficiency runs in your family, this checks whether your activity is low before surgery or pregnancy.
On Warfarin With an Unreliable INR
This can help gauge warfarin effect when INR is distorted, as long as the lab uses the right method.
Living With Amyloidosis or Liver Disease
Both can lower factor X, so checking it can clarify bleeding risk before a procedure.

About Factor X Activity

Factor X activity is most useful when bleeding is real but broad clotting tests don't explain it. A routine PT or aPTT can show that clotting is slow, but it doesn't name which protein is weak. In mild deficiency or some inherited variants, those broad tests may even look close to normal.

Most people never need this test. It matters if you have unexplained bleeding, a known family history of factor X deficiency, an amyloidosis or liver-disease workup, or warfarin monitoring when the INR is hard to trust.

What Factor X Actually Does

Factor X (also written factor 10) is a protein your liver builds using vitamin K. Both main clotting routes feed into it. Once activated, it helps make thrombin. Thrombin makes fibrin. Fibrin is the mesh that gives a clot its strength.

Once factor X becomes factor Xa, it works with factor V, calcium, and the surface of activated platelets to turn prothrombin into thrombin. This test measures working factor X in plasma. It doesn't prove a clot did or didn't form in your body.

What a Low Level Signals

Low factor X activity means less thrombin, weaker fibrin formation, and more bleeding risk as the number falls. In a large European registry of rare bleeding disorders, factor X was one of the single-factor deficiencies where activity lined up clearly with bleeding severity. That link is strong but not absolute: some people bleed more than their level predicts, and even mild deficiency can cause meaningful bleeding. That close tracking is not true for every rare clotting factor.

At the low end, bleeding is often in the skin and mucous membranes: nosebleeds, heavy periods, bleeding gums, easy bruising. Severe inherited deficiency can also bring joint bleeds, bleeding inside the skull, and bleeding from the umbilical stump in newborns.

Inherited Versus Acquired Deficiency

The inherited form comes from variants in the F10 gene and is rare, affecting about 1 in 500,000 to 1 in 1,000,000 people. It is usually recessive. Severe disease tends to show up early in childhood because a child has inherited a harmful variant from both parents.

Acquired deficiency is generally thought to be more common than the very rare inherited form. Liver disease can lower factor X because the liver makes it. Vitamin K deficiency and warfarin lower the activity of factor X and the other clotting proteins that need vitamin K. Amyloidosis is a disease where abnormal proteins build up in tissues. Those deposits can bind factor X and clear it from blood. Rarely, antibodies turn factor X off. These causes are uncommon, but serious bleeding has been reported, so an unexpectedly low result should be explained.

Not a Clot-Risk or Heart Test

It is natural to assume that low factor X means bleeding and high factor X means dangerous clotting. Factor X activity isn't a validated clot-risk marker. A nested case-control study of 1,846 people measured the amount of factor X protein in plasma, not factor X activity, and found no link with heart attack-type events or stroke. An older study did tie high factor X activity to ischemic stroke, but that link didn't hold once other clotting factors were accounted for. Factor XI, a different clotting protein, was linked with ischemic stroke.

Activated factor X can still matter in tissue-level reactions, including liver scarring. That is a different question. A plasma activity result is used to explain bleeding tendency or to help with special anticoagulation problems, not to screen a healthy adult for future clots.

When Results Can Be Misleading

The biggest trap is a blood thinner. Direct factor Xa inhibitors such as apixaban, rivaroxaban, and edoxaban can make factor X activity look low on some assays without proving factor X deficiency. Direct thrombin inhibitors and heparin can also distort clotting assays. Warfarin is different: it truly lowers working factor X because it blocks vitamin K recycling.

Method choice matters too. Some inherited factor X variants read differently depending on the reagent or method the lab uses. Chromogenic factor X can help when INR is unreliable during warfarin therapy, but it is not a clean workaround for direct factor Xa inhibitors, which lower Xa-based readings too. The sample matters as well: blood has to be drawn into a citrate tube, filled correctly, and handled so the plasma doesn't clot before testing.

How the Pattern Is Read

An isolated low factor X result points toward a factor X-specific problem: an inherited variant, amyloidosis, or an antibody. Several low vitamin K-linked factors point instead toward liver disease, vitamin K deficiency, or a vitamin K-blocking drug. Factor V helps separate liver disease from a pure vitamin K problem because it is made by the liver but doesn't depend on vitamin K.

A confirmed inherited deficiency tends to be stable over your lifetime, though factor X naturally rises during pregnancy. Acquired causes move as the cause changes. That is why the useful question after a low result is not just how low it is, but whether the rest of the clotting panel tells the same story.

What Moves This Biomarker

Evidence-backed interventions that affect your Factor X Activity level

Increase
Plasma-derived factor X concentrate (pdFX) infusions
This directly replaces the missing protein and is the preferred treatment for hereditary factor X deficiency when available. It raises plasma factor X activity soon after infusion. In the main prospective study, investigators rated 41 of 42 assessed bleeds as controlled; a small pediatric study controlled 2 of 3 assessed bleeds, and a retrospective study reported control of all 79 assessed bleeds. Regular prevention was rated excellent in 17 of 17 patients across two studies.
MedicationStrong Evidence
Increase
Four-factor prothrombin complex concentrate (4F-PCC)
This blood product contains factor X plus factors II, VII, and IX, so it can raise factor X activity quickly. In randomized trials of major bleeding or urgent procedures during warfarin therapy, 4F-PCC restored vitamin K-linked factor levels faster and with far less volume than plasma.
MedicationStrong Evidence
Decrease
Taking a vitamin K antagonist such as warfarin
Warfarin blocks vitamin K recycling, so your liver makes less working factor X and less of the other vitamin K-linked clotting proteins. A low factor X activity while you take warfarin can reflect the intended anticoagulant effect rather than a new bleeding disorder. If the dose is too strong, bleeding risk rises.
MedicationStrong Evidence
Increase
Correcting vitamin K deficiency
Your liver needs vitamin K to make working factor X. Repleting a true deficiency raises plasma factor X activity along with the other vitamin K-linked clotting proteins. In a small observational study of critically ill adults with prolonged clotting tests, intravenous vitamin K1 raised factor X activity and improved clotting tests within 24 hours.
SupplementModerate Evidence
Increase
High-dose melphalan chemotherapy followed by autologous stem cell transplant for AL amyloidosis
In AL amyloidosis, factor X can be cleared from blood by amyloid deposits. In a retrospective series, factor X improved after high-dose chemotherapy and autologous stem cell transplant in people who had a blood-disease response, because the treatment reduced the abnormal protein driving the deposits.
ProcedureModerate Evidence

Frequently Asked Questions